Oftan Timolol (Timolol Maleate)

Timolol Maleate, the active ingredient in Oftan Timolol, is a beta‑blocking agent presented as a ophthalmic solution for topical eye use. It lowers intra‑ocular pressure and is employed in the management of glaucoma and ocular hypertension in adults.

GNH USA supplies Oftan Timolol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oftan Timolol is a beta‑blocker that reduces aqueous humour production, addressing conditions within the ocular pressure regulation pathway. - Primary open‑angle glaucoma: helps lower intra‑ocular pressure to slow disease progression. - Ocular hypertension: reduces pressure to decrease the risk of developing glaucoma. - Post‑surgical ocular pressure control: assists in maintaining target pressure after eye‑surgery.

Adverse reactions to timolol eye drops may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Burning or stinging sensation upon instillation - Temporary blurred vision - Dry eye or foreign‑body sensation - Conjunctival hyperemia - Mild headache - Reduced tear production

Serious or Rare Side Effects: - Bradycardia or marked heart‑rate reduction - Severe hypotension - Bronchospasm in susceptible individuals - Acute allergic reaction with eyelid swelling - Persistent corneal epithelial defects - Vision loss unrelated to pressure changes

When using Oftan Timolol, consider the following safety measures: - Cardiovascular assessment: evaluate patients with pre‑existing cardiovascular disease or arrhythmias to ensure tolerability. - Respiratory  :     "); - Respiratory  S ; "); -  ");   -  "  " ");  - Store ");  " ". - Store below 5 °C : keep ");  -  t"); -  t"); - "); - "); - "); - "); - Store below "); - "); - Store below 25°C : keep in the original ...

S  t....